Clinical trial

Radiomics for prEdiction of lunG cAncer biologY

NCT05819905

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

Radiomics for prEdiction of lunG cAncer biologY

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusUNKNOWN
Study typeOBSERVATIONAL
Start date2023-01-01
PhaseN/A
Advertisement

Interventions

PET/CTDIAGNOSTIC_TEST

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.